Pfizer expects revenue of $61 billion to $64 billion in 2025, with an estimated $63.23 billion
阿豆学长长ov
发表于 2024-12-17 20:16:04
140
0
0
Pfizer expects revenue of $61 billion to $64 billion in 2025, with an estimated revenue of $63.23 billion; Expected adjusted earnings per share of $2.80 to $3.00 in 2025.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Goldman Sachs: Increases Costco target price to $1052
- Morgan Stanley raises IBM target price to $222
- JPMorgan Chase: Upgrades CBRE rating to $163 increase target price
- Morgan Stanley: Lowering Western Oil Target Price to $63
- Goldman Sachs: Increases Boston Scientific's target price to $103
- Micron Technology's revenue outlook falls short of analysts' expectations, causing its stock price to plummet by approximately 18% after market hours
- Micron Technology's revenue outlook falls short of analysts' expectations, causing its stock price to plummet by approximately 18% after market hours
- Goldman Sachs: Raise Fox's target price to $57
- Citigroup raises Reddit's target price from $120 to $200
- Eli Lilly's new Alzheimer's disease drug launched: annual drug cost exceeds $30000, Pfizer Roche is expanding its strategy